Cost-effectiveness Analysis of Golimumab in the Treatment of Non-Radiographic Axial Spondyloarthritis in Scotland
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2198-6584
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Cost-effectiveness Analysis of Golimumab in the Treatment of Non-Radiographic Axial Spondyloarthritis in Scotland ; volume:5 ; number:1 ; day:9 ; month:4 ; year:2018 ; pages:57-73 ; date:6.2018
Rheumatology and therapy ; 5, Heft 1 (9.4.2018), 57-73, 6.2018
- Creator
-
Borse, Rebekah H.
- Contributor
-
Kachroo, Sumesh
Brown, Chloe
McCann, Eilish
Insinga, Ralph P.
SpringerLink (Online service)
- DOI
-
10.1007/s40744-018-0108-4
- URN
-
urn:nbn:de:101:1-2018070801270653611835
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:34 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Borse, Rebekah H.
- Kachroo, Sumesh
- Brown, Chloe
- McCann, Eilish
- Insinga, Ralph P.
- SpringerLink (Online service)
Other Objects (12)
Differences between radiographic and non-radiographic axial spondyloarthritis patients in a Mexican cohort
Australian Consensus Statements for the Assessment and Management of Non-radiographic Axial Spondyloarthritis
Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and Therapy
Spinal mobility in radiographic axial spondyloarthritis: criterion concurrent validity of classic and novel measurements
Work Disability in Axial Spondyloarthritis
Evidence for the Use of Secukinumab in Patients with Radiographic and Non-radiographic Axial Spondyloarthritis in the Last 5 Years
MRI contributes to accurate and early diagnosis of non-radiographic HLA-B27 negative axial spondyloarthritis
The Risk of Depressive Symptoms Increases in Radiographic Axial Spondyloarthritis Patients with Acute Anterior Uveitis
Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial
Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegol
P190: Cardiovascular Disease in Axial Spondyloarthritis
Novel Therapeutic Targets in Axial Spondyloarthritis
Differences between radiographic and non-radiographic axial spondyloarthritis patients in a Mexican cohort
Australian Consensus Statements for the Assessment and Management of Non-radiographic Axial Spondyloarthritis
Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and Therapy
Spinal mobility in radiographic axial spondyloarthritis: criterion concurrent validity of classic and novel measurements
Work Disability in Axial Spondyloarthritis
Evidence for the Use of Secukinumab in Patients with Radiographic and Non-radiographic Axial Spondyloarthritis in the Last 5 Years
MRI contributes to accurate and early diagnosis of non-radiographic HLA-B27 negative axial spondyloarthritis
The Risk of Depressive Symptoms Increases in Radiographic Axial Spondyloarthritis Patients with Acute Anterior Uveitis
Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial
Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegol
P190: Cardiovascular Disease in Axial Spondyloarthritis
Novel Therapeutic Targets in Axial Spondyloarthritis
Differences between radiographic and non-radiographic axial spondyloarthritis patients in a Mexican cohort
Australian Consensus Statements for the Assessment and Management of Non-radiographic Axial Spondyloarthritis
Non-Radiographic Axial Spondyloarthritis (nr-axSpA): Advances in Classification, Imaging and Therapy
Spinal mobility in radiographic axial spondyloarthritis: criterion concurrent validity of classic and novel measurements
Work Disability in Axial Spondyloarthritis
Evidence for the Use of Secukinumab in Patients with Radiographic and Non-radiographic Axial Spondyloarthritis in the Last 5 Years
MRI contributes to accurate and early diagnosis of non-radiographic HLA-B27 negative axial spondyloarthritis
The Risk of Depressive Symptoms Increases in Radiographic Axial Spondyloarthritis Patients with Acute Anterior Uveitis
Ixekizumab Improves Patient-Reported Outcomes in Non-Radiographic Axial Spondyloarthritis: Results from the Coast-X Trial
Predictors of long-term clinical response in patients with non-radiographic axial spondyloarthritis receiving certolizumab pegol
P190: Cardiovascular Disease in Axial Spondyloarthritis